AQST logo

AQST Aquestive Therapeutics, Inc.

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$3.46
-0.24 (-6.61%)

Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both the United States and international markets. The company's commercialized portfolio includes: Sympazan, an oral soluble film formulation of clobazam for individuals with Lennox-Gastaut syndrome. Suboxone, a sublingual film …

Market Cap: $434.88Mwww.aquestive.com

Price

No data yet.

Social Signal Score

43
5d
50
1 mentions
—
30d
40
7 mentions
—
60d
42
10 mentions
—
90d
40
11 mentions
—
news: 11

Analyst Ratings

10 analysts
Buyconsensus
Strong Buy 0Buy 10Hold 0Sell 0Strong Sell 0
Avg price target$10.5+203.5%
Low $10Median $10.5High $11
Current Consensus

Revenue

$7.56M-54.02%
$7.15M$13.81M$20.48M$27.15M
Mar 2017Sep 2026

Analyst Estimates

FY2025
$-0.62
$-0.64–$-0.59
4 analysts
FY2026
$-0.47
$-0.52–$-0.44
4 analysts
FY2027
$-0.49
$-0.62–$-0.40
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Daniel Barber
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
147
Beta
1.50
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-4.93
www.aquestive.com